Fact CheckerSign in

NCT01471483Completed

Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer

Source: ClinicalTrials.gov · Last updated 23 Apr 2025

Brief summary (registry, in English)

Older woman with ovarian cancer have a worse prognosis compared to younger patients. However, the reason is not known. Currently, the standard of care is to evaluate younger and older patients with cancer the same way. However, older patients with cancer often have more complicated issues to manage. For example, older patients often have other medical problems, take more medications, and be dependent on others for help and transportation. Too often, the medical team is unaware of these issues which can effect the patients care. The purpose of this study is to apply a set of questions designed specifically for patients with cancer who are older than 65 years of age. These questions are called a geriatric assessment. The investigators want to better understand which older patients with ovarian cancer will be able to tolerate the chemotherapy and surgery and why. This study will also see if a telephone call from a nurse who specializes in caring for older patients will improve patient care. This study will determine how feasible it is to perform geriatric assessments and telephone calls in patients with ovarian cancer.

Status (registry)
Completed
Study type
Observational
Enrollment
50 (estimated)
First submitted
10 Nov 2011
Start date
Nov 2011
Primary completion date
Apr 2025
Lead sponsor
Memorial Sloan Kettering Cancer Center
NCT number
NCT01471483

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From Nov 2011 to the primary completion date, Apr 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Enrolled on a phase I trial.

Who the study is looking for

  • Patients must be \> or = to age of 65. Will receive platinum-based chemotherapy and surgery at MSKCC for stage II-IV ovarian, fallopian tube or peritoneal cancer.
  • Pathologic confirmation or high suspicion based on Ca125 level and/or radiologic evidence of ovarian, fallopian tube or peritoneal cancer.
  • Able to understand English.
  • Be able to provide informed consent.

Age in the registry: 65 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan Kettering Cancer Center at Commack
Coordinator of this site? Confirm its status
CommackUnited StatesUnknown status
Memorial Sloan Kettering Cancer Center @ Suffolk
Coordinator of this site? Confirm its status
CommackUnited StatesUnknown status
Memorial Sloan-Kettering Cancer Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.